Literature DB >> 11886852

Regulation of phospholipase C-gamma activity by glycosphingolipids.

Liming Shu1, Lihsueh Lee, James A Shayman.   

Abstract

Glycosphingolipid-enriched domains are hot spots for cell signaling within plasma membranes and are characterized by the enrichment of glycosphingolipids. A role for glucosylceramide-based glycosphingolipids in phospholipase C-mediated inositol 1,4,5-trisphosphate formation has been previously documented. These earlier studies utilized a first generation glucosylceramide synthase inhibitor to deplete cells of their glycosphingolipids. Recently, more active and specific glucosylceramide synthase inhibitors, including d-threo-ethylendioxyphenyl-2-palmitoylamino-3-pyrrolidinopropanol (d-t-EtDO-P4), have been designed. d-t-EtDO-P4 has the advantage of blocking glucosylceramide synthase at low nanomolar concentrations but does not cause secondary elevations in cell ceramide levels. In the present study, d-t-EtDO-P4 depleted cellular glucosylceramide and lactosylceramide in cultured ECV304 cells at nanomolar concentrations without obvious cellular toxicity. The expression of several signaling proteins was evaluated in glycosphingolipid-depleted ECV304 cells to study the role of glycosphingolipids in phospholipase C-mediated signaling. No difference was observed in the cellular expression of phospholipase C-gamma between controls and glycolipid-depleted cells. Western blot analysis, however, revealed that depletion of endogenous glycosphingolipids in cultured ECV304 cells with d-t-EtDO-P4 induced tyrosine phosphorylation of phospholipase C-gamma in a concentration-dependent manner with maximum induction at 100 nm. The phosphorylation of phospholipase C-gamma induced by d-t-EtDO-P4 was abolished by exogenously added glucosylceramide, consistent with a specific glycosphingolipid-phospholipase C-gamma interaction. The phospholipase C-gamma phosphorylation was maximally enhanced by bradykinin when cells were exposed to 100 nm d-t-EtDO-P4. The measurement of cellular activity of phospholipase C-gamma, by myo-inositol 1,4,5-trisphosphate radioreceptor assay, demonstrated that depletion of glucosylceramide-based glycosphingolipids in cultured ECV304 cells with d-t-EtDO-P4 resulted in significantly increased formation of inositol 1,4,5-trisphosphate above base line, and an increased sensitivity of phospholipase C-gamma to bradykinin stimulation. Thus, the activation of phospholipase C-gamma is negatively regulated by membrane glycosphingolipids in ECV304 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11886852     DOI: 10.1074/jbc.M111363200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Impaired proteolysis underlies autophagic dysfunction in Niemann-Pick type C disease.

Authors:  Matthew J Elrick; Ting Yu; Chan Chung; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2012-08-07       Impact factor: 6.150

2.  Vascular dysfunction in the alpha-galactosidase A-knockout mouse is an endothelial cell-, plasma membrane-based defect.

Authors:  James L Park; Steven E Whitesall; Louis G D'Alecy; Liming Shu; James A Shayman
Journal:  Clin Exp Pharmacol Physiol       Date:  2008-06-18       Impact factor: 2.557

3.  Specific glycosphingolipids mediate epithelial-to-mesenchymal transition of human and mouse epithelial cell lines.

Authors:  Feng Guan; Kazuko Handa; Sen-itiroh Hakomori
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-20       Impact factor: 11.205

4.  Differential involvement of COX1 and COX2 in the vasculopathy associated with the alpha-galactosidase A-knockout mouse.

Authors:  James L Park; Liming Shu; James A Shayman
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-06       Impact factor: 4.733

5.  Glycosphingolipid Mediated Caveolin-1 Oligomerization.

Authors:  Liming Shu; James A Shayman
Journal:  J Glycomics Lipidomics       Date:  2012-02-18

6.  Ganglioside GM3 has an essential role in the pathogenesis and progression of rheumatoid arthritis.

Authors:  Yukinori Tsukuda; Norimasa Iwasaki; Naoki Seito; Masashi Kanayama; Naoki Fujitani; Yasuro Shinohara; Yasuhiko Kasahara; Tomohiro Onodera; Koji Suzuki; Tsuyoshi Asano; Akio Minami; Tadashi Yamashita
Journal:  PLoS One       Date:  2012-06-29       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.